Viewing Study NCT06265233


Ignite Creation Date: 2025-12-25 @ 2:49 AM
Ignite Modification Date: 2025-12-26 @ 1:31 AM
Study NCT ID: NCT06265233
Status: COMPLETED
Last Update Posted: 2025-05-28
First Post: 2024-02-09
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: ERP Plus Improv Group Therapy for OCD (IMPROVE Study)
Sponsor: Stanford University
Organization:

Study Overview

Official Title: Pilot Study of Cognitive Behavioral Therapy (CBT) Plus Improv Group Therapy for OCD
Status: COMPLETED
Status Verified Date: 2025-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The goal of this study is to pilot test a novel group therapy intervention for adults with OCD.
Detailed Description: The intervention will incorporate exposure and response prevention (ERP) with improvisational comedy ("improv") activities. ERP is the gold-standard treatment for OCD. Improv comedy is a type of theater in which actors perform without a script. This study aims to evaluate whether the intervention is helpful for reducing OCD symptoms and intolerance of uncertainty (a mechanism maintaining OCD). It will also explore whether the intervention is feasible and acceptable.

During the group therapy sessions, participants will engage with improv comedy exercises that have been adapted to function as exposures for different types of OCD. Participants will:

* attend an ERP + improv group therapy intervention (90-minute sessions for 12 weeks)
* complete homework in-between sessions
* answer questions
* complete questionnaires.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: